Question of the study: Prevalence and determinants of daytime hy� poxemia in patients with obstructive sleep apnea (OSA) syndrome are not well established. The aims of this study, conducted in a large se�
SLEEP APNEA IS A CHRONIC CONDITION CHARACTER-IZED BY UPPER AIRWAY COLLAPSE DURING SLEEP.
THE RESULTING DECREASE OR CESSATION OF airflow is generally associated with recurrent drops in oxyhemoglobin saturation. Gas exchange during sleep may be severely affected in certain patients, especially in those who are grossly obese or have chronic respiratory disorders, such as chronic obstructive pulmonary disease (COPD).
1-2 Daytime hypoxemia has been reported to develop in patients with obstructive sleep apnea (OSA).
3-8 In the past, looking for the physiological determinants of nocturnal arterial oxygenation in OSA patients, it was found that derangements of pulmonary mechanics and awake PaO 2 were of major importance in establishing the severity of nocturnal hypoxemia.
9
Other studies showed that the main determinant of daytime hypoxemia is not the OSA per se but rather concomitant comorbidity such as COPD. [7] [8] 10 However, all these studies were performed on heterogeneous populations with a very high prevalence of COPD patients, so that airway obstruction and lung hyperinflation had major roles in determining the lower values of PaO 2 . Moreover, the PaO 2 level at rest is highly dependent on age, and none of the studies previously cited corrected the level of PaO 2 for age, thus invalidating any comparisons of the level of oxygenation in patients with widely different ages.
The aims of the current study were: (i) to estimate the prevalence of alterations in daytime oxygenation in a very large group of OSA patients with a very broad spectrum of disease severity and obesity; (ii) to assess the reciprocal (feedback) effects between daytime PaO 2 and nocturnal SaO 2 , adjusted for comorbidities such as obesity and lung volumes; and (iii) to investigate the direct and indirect role of sleep apnea severity in determining feedback gas exchange abnormalities. Some of the results of this study have been previously reported in the form of an abstract.
11

METHODS
Patients and Study Design
We studied 456 consecutive patients (49.4 ± 10.7 years, 160 females) who complained of snoring and excessive daytime sleepiness and had been consecutively referred to our laboratory for investigations of possible OSA. These investigations consisted of standard polysomnography and, the day after, determination of static and dynamic lung volumes and blood gas measurements. Patients with previously diagnosed or radiologically evident respiratory diseases, radiologically evident lung lesions (e.g., previous tuberculosis treated physically, pulmonary abscesses, pneumothorax), neuromuscular disorders (e.g., post-polio lesions), chest-wall defects, previous use of appetite suppressants or a clinical history of venous thromboembolic disease, a bronchopulmonary infection, or cardiac or respiratory failure in the preceding 6 months were excluded from the study, as were patients with a previous diagnosis of pulmonary arterial hypertension.
The protocol was submitted to the Technical and Ethical Committees. The former approved the protocol and the latter stated that approval was waived since, on admission to hospital,
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The Relationship of Daytime Hypoxemia and Nocturnal Hypoxia in Obstructive Sleep Apnea Syndrome patients are asked to sign whether they consent or not to the use of their medical records and "routine" examination results for research purposes. We analyzed only records of patients who agreed to the use of their data.
Measurements
Sleep Study
Full standard in-laboratory polysomnography (Embla, Medcare, Reykyiavik, Iceland) was performed using current procedures and scored manually according to the criteria of Rechtschaffen and Kales.
12 The polysomnography included: EEG s (C 3 -A 2 , C 4 -A 1 ), EOG s , submental EMG, anterior tibialis electromyograms, nasal cannula airflow signal using a nasal cannula/ pressure transducer system, oral thermistor, ECG and body position. SpO 2 was recorded by means of an in-built pulse oximeter (Nonin Medical Inc., Minneapolis, MN, USA) with an Oximax sensor (Nellcore, Pleasanton, CA, USA). The equipment provides both an averaged (4 seconds) and a beat-to-beat SpO 2 value. Respiratory efforts were monitored by the plethysmographic method (X-trace, Medcare, Iceland), so that the sum of thoracic and abdominal activities was obtained.
Arousals were scored according to standard criteria. 13 Apnea was defined as a cessation of airflow for ≥10 seconds, while hypopnea as a clear amplitude reduction of a validated measure of breathing during sleep (but less than a 50% reduction from baseline) associated with an oxygen desaturation of >3% or an arousal.
14 We determined the apnea-hypopnea index (AHI), and the oxygen desaturation index (ODI), and the percent sleep time spent with SpO 2 <90% (TST 90 ).
Evaluation of Daytime Respiratory Function and Blood Gas assays
Pulmonary function tests (Masterlab, Jaeger, Hochberg, Germany) were performed as described in the European Respiratory Society statement. 15 Respiratory function data were compared with predicted normal values obtained using the European Community for Steel and Coal (ECSC) 1983 regression equations. Diffuse airway obstruction was defined as a FEV 1 < 70% of predicted and FEV 1 /VC <60%, according to a previous study.
6
Arterial blood-gases were analyzed by an automated, computerized gas analyzer (ABL 550, Radiometer, Copenhagen, Denmark). PaO 2 was adjusted for age and expressed as percent of predicted according to a reference equation for the Italian population. 16 All the measurements were performed between 10:00 and 12:00 a.m. Daytime hypoxemia was defined as PaO 2 % <90%, while nocturnal hypoxia was defined as TST 90 > 1%.
Statistical analysis
Results are expressed as mean ± SD, and t-tests considering equal or unequal variances were used to compare data among the two groups of patients classified by the dichotomized definitions of TST 90 and PaO 2 . Pearson's r correlation coefficients and forward stepwise regression analyses were performed to evaluate bivariate associations between pairwise variables, and the predictors that explain the variance of continuous measurements of TST 90 and PaO 2 , respectively.
The relationship between daytime hypoxemia and nocturnal hypoxia was investigated by structural equations modeling (SEM). 17, 18 This is a statistical multivariate approach based on the use of a system of simultaneous equations to describe a priori relationships of observed (manifest) and unobserved (latent) variables of the physical process that generates the data.
A special type of structural equations modeling is the Path Analysis model in which only observed variables are considered in simultaneous equations. Path Analysis distinguishes three types of effects: direct, indirect, and total effects. The direct effect of an explanatory variable on a response variable is the net effect of a predictor setting all the other predictors in the built-in equations being equal. The indirect effect of an explanatory variable is the effect mediated by the pathway relationships of the other variables built-in the equations. The total effect is the sum of both the direct and indirect effects: total effect = direct effect + indirect effect. The decomposition of effects is always with respect to a specific model. An arrow from one variable to another indicates that the first variable has a direct influence on the second, two straight single-headed arrows connecting two variables indicate a reciprocal direct influence, and a curved two-headed arrow signifies a correlation between two variables. The path coefficients displayed on the arrows are the regression coefficients for the observed variables, and the residual variances/covariances for the unobserved errors. (*) VC%: vital capacity in % of predicted; BMI: body mass index (Kg/m 2 ); TST 90 : percent sleep time spent with SaO 2 <90%; PaO 2 %: partial oxygen arterial pressure in % of predicted; ODI: oxygen desaturation index; AHI: apnea-hypopnea index. The SEM is written as: TST 90 = α 1 BMI + α 2 VC % + α 3 PaO 2% + α 4 ODI + α 5 AHI + e 1 PaO 2% = β 1 BMI + β 2 VC % + β 3 TST 90 + e 2 var (e 1 )= σ 1 ; var (e 2 )= σ 2 ; cov (e 1 ; e 2 ) = σ 12 AHI and ODI) in determining TST 90 −PaO 2 % feedback, adjusted for obesity (expressed by BMI), and lung volumes (expressed by VC%). A gender stratification analysis was also planned.
The structural equations were fitted using maximum likelihood estimates (MLE). The χ 2 difference test of "fitted" vs. "saturated" models was used for hypothesis testing to evaluate the appropriateness of the feed-back model; large P-value (P > 0.05) was the criteria for data support. The regression parameter estimates (direct, indirect, and total effects) of simultaneous equations were re-expressed in a standardized form multiplying the unstandardized one by 1 standard deviation (SD) of the explanatory variables. The P-values of the direct, indirect, and total estimates were evaluated by t-tests (=estimate/standard error) using robust standard errors; the level of statistical significance was set at P < 0.05, two-sided.
Descriptive and exploratory statistics were analyzed with SPSS 13.0 software (www.spss.com), while the feedback structural equations modeling was performed with Mplus 3.11 software (www.statmodel.com).
RESUlTS
All patients enrolled completed the study. The mean PaO 2 value was lower than expected on the basis of age (80.2% ± 10.7% of predicted). Fourteen patients (3% of 456 patients) had diffuse airway obstruction but they did not differ (P >0.05) from the remaining for PaO 2 % of predicted (76.3% ± 12.3% vs. 80.3% ± 10.7%), AHI (46.8 ± 22.3 vs. 48.4 ± 33.4) or TST 90 (31.2 ± 39.6 vs. 24.2 ± 30.1). As expected, the patients with diffuse airway obstruction were older (age 60.7 ± 6.6 vs. 49.1 ± 12.2 yrs, P<0.001) and less obese (BMI 34.8 ± 6.9 vs. 42.7 ± 10.9 kg/m 2 , P = 0.01) than the entire sample.
The great majority of patients (81.6% of the 456 patients, 95% CI: 78.0% to 85.1%) had a PaO 2 <90% of predicted. As shown in Table 1 , the subjects with preserved PaO 2 were older, and less obese than the patients with PaO 2 <90% of predicted. The absolute FEV 1 /VC ratio was similar in these two groups of patients; while patients with daytime PaO 2 >90% of predicted showed lower mean values of AHI, ODI, and TST 90 in comparison with patients with daytime hypoxemia.
The great majority of patients (79.4% of the 456 patients, 95% CI: 75.7% to 83.1%) had altered gas exchange during sleep, defined as TST 90 >1% of total sleep time. As shown in Table 2 , patients with nocturnal hypoxia had smaller lung volumes, but similar FEV 1 /VC ratio, functional residual capacity and residual volumes. In contrast, they had more severe sleep apnea and more impaired daytime PaO 2 .
A stepwise regression procedure included the predictors VC, BMI, AHI, ODI, and PaO 2 % in the regression equation of TST 90 from all the potential predictor variables listed in Table  2 ; while VC, BMI, and TST 90 were the selected predictors in the regression equation of PaO 2 % from all the potential predictor variables listed in Table 1 (data not shown). The results of separate linear regression models for PaO 2 % and TST 90 were used to define the Path Analysis model with the addition of the feedback loop.
The maximum likelihood estimates and robust 95% CI of the standardized regression coefficient parameters (=average change of the response variable by 1 standard deviation (SD) increment of the explanatory variable) for the TST 90 -PaO 2 feedback structural equations of Figure 1 are reported in Table 3 . The chi-square testing (χ 2 =3.242, df = 1, P = 0.072 NS) provided evidence of the appropriateness of the feedback model given the observed data. The two feedback structural equations 
DiSCUSSiOn
The main findings of this study are: (i) patients with OSA, in the absence of lung comorbidity such as diffuse airway obstruction, had lower values of PaO 2 than those expected on the basis of age; and (ii) a feedback model of daytime hypoxemianocturnal hypoxia (Figure 1 ) was not supported, even after adjustment for obesity and lung volume, and gender stratification. An increase of percent sleep time with reduced SpO 2 is associated with a decrease in daytime PaO 2 , while the level of nocturnal SpO 2 is not related to the level of daytime PaO 2 . Moreover, because nocturnal hypoxia is related to the severity of OSA (expressed by AHI and ODI), the level of nocturnal SaO 2 is also a mediator of the severity of the OSA effect on daytime hypoxemia.
We performed the present study in an attempt to determine the direction of the relationship between daytime hypoxemia and nocturnal hypoxia. This issue is related to an appropriate definition of daytime hypoxemia and an appropriate identification of the population of patients. Firstly, most of the previous papers reported that a normal value of PaO 2 at rest is ≥80 mm Hg, hypoxemia is present when the PaO 2 is below 80 mm Hg, and severe hypoxemia when the PaO 2 is ≤65 mm Hg. 1, 3, 7, 8, 10 None of these studies adjusted the PaO 2 values for age, obesity or lung volumes. We corrected the PaO 2 data according to the reference equation for the Italian population, thus defining the PaO 2 as a percent of predicted. In this way, we found that the great majority of subjects had reduced PaO 2 values. Indeed, only 84 (18%) patients had a PaO 2 higher than 90% of predicted. This result did not change when different reference values of PaO 2 published in the literature were applied (data not shown), 19, 20 or when the PaO 2 was considered as an absolute value. explained 34.2% and 31.3% of the total variance of continuous measurements of TST 90 and PaO 2 %, respectively, while the residual correlation between TST 90 and PaO 2 % was fixed to 0 to ensure that the regression parameters of the estimated structural model were identified.
The daytime PaO 2 % of predicted was statistically significantly associated (P<0.001) with the feedback effect of nocturnal hypoxia (TST 90 ) and with the effects of obesity (BMI) and lung volumes (VC%). Specifically, an increment of 1 SD (30.5%) of TST 90 produced a reduction of 3.96% (95% CI: -2.11% to -5.82%) in the PaO 2 % of predicted; an increment of 1 SD (11.3 kg/m 2 ) of BMI produced a decline of 3.33% (95% CI: -2.14% to -4.53%); and an increment of 1 SD (15%) of VC% produced a rise of 1.5% (95% CI: +0.59% to +2.41%).
In contrast, the daytime PaO 2 feedback effect did not influence (P = 0.965) the extent of nocturnal hypoxia, which was statistically significantly related with the severity of OSA (P <0.001), and background measurements (BMI, P = 0.020 and VC%, P<0.001). Specifically, an increment of 1 SD (33 events/1 hour) in the AHI or ODI increased TST 90 by 7.99% (95% CI: +3.63% to +12.3%) or 7.01% (95% CI: +2.45% to +11.6%), respectively; TST 90 also increased by 3.91% (95% CI: +0.61% to +7.21%) for 1 SD of BMI and declined 4.91% (95% CI: -2.24% to -7.58%) for 1 SD of VC%.
The above described changes were net effects (direct effects); however, the severity of OSA, expressed by AHI and ODI, also had statistically significant indirect effects (P = 0.009) on daytime hypoxemia via the nocturnal hypoxia pathway, i.e., TST 90 is a variable that mediates the effect of OSA on PaO 2 outcome. Specifically, via the TST 90 path, an increment of 1 SD in the AHI or ODI decreased PaO 2 % of predicted by about 1% (95% CI: -0.25% to -1.81% for AHI, and -0.28% to -1.58% for ODI).
None of the results changed if PaO 2 was considered in absolute values rather than in % of predicted.
Stratification according to gender did not show any major The development of daytime hypoxemia in OSA patients has generally been related to the presence of subclinical arterial pulmonary hypertension (PH). [3] [4] [5] [6] However, this association with pulmonary hypertension is now a matter of discussion since most of the studies produced conflicting results. It should be considered that all the studies that gave negative results were the oldest ones and the ones with a relevant percentage of COPD patients, as stated above. [1] [2] [3] [7] [8] 10 There is, however, a growing body of evidence that highlights the role of sleep apnea in the development of daytime gas exchange abnormalities through the pathophysiological effect of chronic intermittent hypoxia. The occurrence of PH in OSA patients without concomitant lung disease ranged from 20% to 43%. [4] [5] [6] 24 In all these studies PH patients had a more altered nocturnal gas exchange and in two of them a lower level of daytime PaO 2 .
6,24
The increasing of pulmonary arterial pressure has been associated with hypoxia-induced pulmonary vasoconstriction. 5, 25, 26 Animal models showed increases in right ventricular mass, hematocrit level and pulmonary arterial pressure during exposure to chronic intermittent hypoxia or asphyxia.
27,28 Chronic intermittent hypoxia activates homeostatic mechanisms in the respiratory system that induce changes in gene expression by mediation of several transcription factors, such as hypoxiainducible factor (HIF).
29 Experimental data showed that hypoxia inducible factors (both HIF-1α and HIF-2α) are involved in physiological responses of pulmonary arterioles to chronic intermittent hypoxia, collectively producing hypertrophy and depolarization of pulmonary arteriolar smooth muscle.
29
Recent studies suggested that the hypoxia inducible factor-1 pathway response to chronic intermittent hypoxia seems to be activated only in patients with moderate to severe nocturnal gas exchange alterations. 30 These patients showed a significantly increased level of erythropoietin during sleep, differently from patients with less severe OSA.
31 On the contrary, in these latter chronic intermittent hypoxia activated a different pathway mediated through the transcription factor nuclear factor-κB that, in turn, increased the expression of tumor necrosis factor-α, which
The second point regards the choice of the population of the patients. In the present study we included consecutive patients with sleep apnea, so that all biases related to disordered respiratory mechanics could be excluded. This was not the case in the previous studies in which a significant proportion of patients, ranging from 11% to 25%, were affected by concomitant COPD, with the prevalence of COPD, sometimes with FEV 1 < 1 litre. 1, 3, [7] [8] 10 In COPD, peripheral airway obstruction, parenchymal destruction, and pulmonary vascular abnormalities reduce the lung's capacity for gas exchange, producing hypoxemia and, later on, hypercapnia.
21 Since daytime PaO 2 data were not corrected for age or lung function and, since subjects with concomitant COPD were older than those with simple OSA, the effect of age and lung function impairment in determining lower values of PaO 2 were mutually enhanced.
22
We found that TST 90 , an index of nocturnal hypoxia, was a valuable determinant of the development of daytime hypoxemia, even after adjustment for the degree of obesity, lung volumes and sex stratification. AHI and ODI, expressions of the severity of sleep apnea, were also significant determinants although their effect was mediated through TST 90 . Of interest, the level of TST 90 appears independent of daytime PaO 2 , because the feedback (reciprocal) effect was not supported. This latter is an intriguing observation since in the past it was hypothesized that a low level of daytime PaO 2 may account for the severity of the nocturnal hypoxia.
10 Indeed, Bradley et al. observed, in a group of OSA patients, that the main predictors of nocturnal desaturation, expressed by the mean value of SaO 2 across the night, were daytime PaO 2 , alterations in respiratory mechanics (again mainly related to airway obstruction and the degree of obesity), and the sleep time spent in apnea. On the contrary, our results are in agreement with data, reported by Sanders et al, obtained from the Sleep Heart Health Study.
23 They found that patients with sleep apnea without obstructive airway disease had a 20-fold higher odds ratio for nocturnal desaturation than that of healthy subjects, even after adjustment for age, sex, height, weight, race, smoking status and awake SaO 2 . Finally, most of the patients enrolled in our study were obese and therefore caution needs to be exercised regarding the generalizability of our findings. However, all the results were statistically adjusted for the level of obesity so that the effect of this anthropometric parameter in our specific cohort could be minimized.
In conclusion, our data support the evidence that nocturnal hypoxia seems to be both a direct determinant and a mediator of the indirect effect of sleep apnea on the development of daytime hypoxemia. Follow-up studies are needed to evaluate the time course of daytime gas exchange abnormalities and to assess the role of therapy in stopping or slowing down this evolution. may contribute to endothelial dysfunction.
32 Finally, treatment with CPAP has been demonstrated to reduce pulmonary arterial pressure levels also in patients with a pressure <20 mm Hg. 26, 33 However, daytime hypoxemia in OSA patients may develop through mismatching of ventilation and perfusion, as a result of different mechanisms, such as changes in mechanical properties of the lung or development of subclinical interstitial pulmonary edema. An increase in elastance of the whole lung during sleep was found in patients with OSA.
34 Sleep may induce a loss in the mechanical coupling between airways and lung parenchyma which, in turn, allows the airways to narrow more easily. 35 Alternatively, the reduction of lung volumes during sleep could not only decrease parenchymal attachments but also increase the forces arising from surface tension, which would lead to an increase in elastance. Indeed, it was shown that the severity of apnea-induced desaturation was correlated with lung volume, particularly with the difference between supine expiratory reserve volume and seated closing volume. 36 These mechanical modifications may induce closure of some respiratory units during upper airway obstruction, which is reversed at the end of the obstruction. These transient abnormalities in the recruitment of lung units resulting in air space closure reduce the gas exchange capacity of the lungs independently from the level of daytime gas exchange.
34
Chronic intermittent hypoxia induces proliferation of the vasculature due to angiogenesis but can also change the integrity of vessels, leading to changes in vascular permeability. 37 Fletcher et al., in a canine model of OSA, demonstrated that pulmonary edema can develop after recurrent obstructive apneas.
38 They found a significant deterioration of gas exchange in those animals with histologic and/or electron microscopy evidence of lung edema compared to those without edema and controls and a substantial fall in the amplitude of apnea desaturation related to deterioration of gas exchange. It has been demonstrated that hypoxia induces angiogenesis upregulating the vascular endothelial growth factor (VEGF).
39 Schulz et al. found that the serum levels of VEGF are elevated in severely hypoxic patients with OSA and are related to the degree of nocturnal oxygen desaturation. 40 Of interest, patients with the highest degree of nocturnal desaturation were those with the lowest level of daytime PaO 2 .
Recently, Guardiola et al. suggested that the mechanical changes and increased interstitial lung water described above were not immediately reversed since they found that OSA patients had lower PaO 2 values in the morning than in the evening.
41
A possible limitation of our study, like that of the other studies, is the lack of information about the intensity and duration of exposure to nocturnal hypoxia. Different durations of disease, or, more probably, an early onset of OSA may contribute to explain the variability between the results we obtained and those of the previous studies. One particularly complex methodological issue in characterizing the progression of OSA is the worsening epidemic of obesity in western countries such that it can be very difficult to separate the effects on gas exchange of prolonged OSA from those related to increasing body weight. 42 Indeed, a longitudinal study on sleep disordered breathing performed in a nonclinic population found that changes in the respiratory disturbance index over time do not vary uniformly with age, sex, and weight.
